Activation of the constitutive androstane receptor decreases HDL in wild-type and human apoA-I transgenic mice
Open Access
- 1 August 2008
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 49 (8) , 1682-1691
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- The Constitutive Androstane Receptor and Pregnane X Receptor Function Coordinately to Prevent Bile Acid-induced HepatotoxicityJournal of Biological Chemistry, 2004
- Human Constitutive Androstane Receptor Mediates Induction of CYP2B6 Gene Expression by PhenytoinJournal of Biological Chemistry, 2004
- A Novel Constitutive Androstane Receptor-Mediated and CYP3A-Independent Pathway of Bile Acid DetoxificationMolecular Pharmacology, 2004
- Apolipoprotein CI Deficiency Markedly Augments Plasma Lipoprotein Changes Mediated by Human Cholesteryl Ester Transfer Protein (CETP) in CETP Transgenic/ApoCI-knocked Out MiceJournal of Biological Chemistry, 2002
- Cholesterol and Bile Acids Regulate Xenosensor Signaling in Drug-mediated Induction of Cytochromes P450Journal of Biological Chemistry, 2002
- Effect of Antiepileptic Drugs on Plasma Lipoprotein (a) and Other Lipid Levels in ChildhoodJournal of Child Neurology, 2001
- Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.Journal of Clinical Investigation, 1996
- Binding Specificity and Modulation of the ApoA-I Promoter Activity by Homo- and Heterodimers of Nuclear ReceptorsJournal of Biological Chemistry, 1996
- A Prospective, Randomized Trial of Phenytoin in Nonepileptic Subjects With Reduced HDL CholesterolArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Effects of Phenytoin on Plasma High‐Density Lipoprotein Cholesterol Levels in Men with Low Levels of High‐Density Lipoprotein CholesterolThe Journal of Clinical Pharmacology, 1995